Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.

Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial.

<h4>Background</h4>Emerging evidence suggests aspirin may be an effective venous thromboembolism (VTE) prophylaxis for orthopaedic trauma patients, with fewer bleeding complications. We used a patient-centered weighted composite outcome to globally evaluate aspirin versus low-molecular-w...

Full description

Bibliographic Details
Main Authors: Bryce E Haac, Nathan N O'Hara, Theodore T Manson, Gerard P Slobogean, Renan C Castillo, Robert V O'Toole, Deborah M Stein, ADAPT Investigators
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0235628

Internet

https://doi.org/10.1371/journal.pone.0235628

Similar Items